Chronic Myeloid Leukemia Blast Phase
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia Blast Phase.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating ponatinib in combination with chemotherapy for acute lymphoblastic leukemia and BCR-ABL1-positive leukemias, includ…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers [Phase 2]
Phase 2 trial evaluating Dexrazoxane hydrochloride to prevent heart-related side effects of chemotherapy in people with blood cancers; the s…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
This Phase 1 trial update reports on the use of sorafenib in patients with refractory or relapsed acute leukemia, myelodysplastic syndromes,…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia [Phase 1]
This document reports the completion of a Phase 1 study evaluating the HSP90 inhibitor STA-9090 (ganetespib) in patients with acute myeloid …
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia [Phase 1]
A Phase 1 trial evaluating bortezomib in pediatric patients with refractory or recurrent leukemia, including blast-phase chronic myeloid leu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 study of BMS-354825 (dasatinib) in patients with chronic myeloid leukemia in chronic, accelerated, or blast phases and Philadelphi…